GlassScriptPhysician profile
Robert G Parker
NPI 1699865212
$787.44
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $649 · 2020: $138.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $100.75 | 2019 | |
| Amgen INC. | $97.36 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $87.18 | 2019 | |
| Novo Nordisk INC | $76.92 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $63.01 | 2019-2020 | |
| Pfizer INC. | $51.05 | 2019 | |
| Glaxosmithkline, LLC. | $49.74 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $45.05 | 2019-2020 | |
| Gilead Sciences, INC. | $38.29 | 2019-2020 | |
| Allergan, INC. | $28.31 | 2019 | |
| Novartis Pharmaceuticals Corporation | $18.20 | 2020 | |
| Hologic Sales and Service, LLC | $16.34 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $14.22 | 2019 | |
| Astellas Pharma US INC | $13.49 | 2019 | |
| Lilly USA, LLC | $13.43 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $13.03 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $12.62 | 2020 | |
| Biogen, INC. | $12.40 | 2020 | |
| Arbor Pharmaceuticals, INC. | $12.35 | 2019 | |
| Antares Pharma, INC. | $12.19 | 2019 | |
| Amarin Pharma, INC. | $11.51 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Parker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.